Association between coronary endothelial dysfunction and local inflammation of atherosclerotic coronary arteries

Molecular and Cellular Biochemistry

Volumn 249, Issue 1-2, 2003, Pages 67-73

  Matsubara, Taku ^a   Ishibashi, Takaharu ^b   Hori, Tomoyuki ^c   Ozaki, Kazuyuki ^c   Mezaki, Tohru ^c   Tsuchida, Keiichi ^c   Nasuno, Akimitsu ^c   Kubota, Kaname ^c   Tanaka, Takayuki ^c   Miida, Takashi ^c   Aizawa, Yoshifusa ^c   Nishio, Matomo ^b  

^a Shinrakuen Hospital   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

C reactive protein; Coronary atherosclerosis; Endothelial function; Inflammation; Nitric oxide; Serum amyloid A protein

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; NITRATE; NITRIC OXIDE; NITRITE; SERUM AMYLOID A;

ADULT; AGED; ANGIOCARDIOGRAPHY; AORTA ROOT; ARTERY ENDOTHELIUM; ARTICLE; BLOOD SAMPLING; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY SINUS; CORRELATION FUNCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; INFLAMMATION; LEFT CORONARY ARTERY; MALE; MEASUREMENT; SCORING SYSTEM; STATISTICAL ANALYSIS; TURBIDIMETRY;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; NITRIC OXIDE; NITRITES; SERUM AMYLOID A PROTEIN;

EID: 12444267900     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024778421491     Document Type: Article

References (28)

1. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A: Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101: 948-954, 2000
2. Schächinger V, Britten MB, Zeiher AM: Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101: 1899-1906, 2000
3. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Masari A: The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 331: 417-424, 1994
4. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, Braunwald E: Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy. J Am Coll Cardiol 35: 358-362, 2000
5. Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A, Summaria F, Ginnetti F, Fadda G, Maseri A: Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 99: 855-860, 1999
6. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336: 973-979, 1997
7. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342: 836-843, 2000
8. Umans JG, Levi R: Nitric oxide in the regulation of blood flow and arterial pressure. Annu Rev Physiol 57: 771-790, 1995
9. Node K, Kitakaze M, Yoshikawa H, Kosaka H, Hori M: Reduced plasma concentrations of nitrogen oxide in individuals with essential hypertension. Hypertension 30: 405-408, 1997
10. Quyyumi AA, Dakak N, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon RO III: Nitric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol 29: 308-317, 1997
11. Ramesh G, Varma JS, Ganguly NK, Dhawan V, Bali HK, Singh M: J Mol Cell Cardiol 31: 1495-1500, 1999
12. 3 - difference in human coronary circulation with severe atherosclerotic stenosis. Life Sci 66: 173-184, 2000
13. Hori T, Matsubara T, Ishibashi T, Yamazoe M, Ida T, Higuchi K, Takemoto M, Ochiai Y, Tamura Y, Aizawa Y, Nishio M: Decrease of nitric oxide end-products during coronary circulation reflects elevated basal coronary artery tone in patients with vasospastic angina. Jpn Heart J 41: 583-595, 2000
14. Gensini GG: A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51: 606, 1983
15. Ishibashi T, Kubota K, Himeno M, Matsubara T, Hori T, Ozaki K, Yamazoe M, Aizawa Y, Yoshida J, Nishio M: Respiratory alkalosis does not alter NOx concentrations in human plasma and erythrocytes. Am J Physiol 281: H2757-H2761, 2001
16. Hoffmeister A, Rothenbacher D, Bäzner U, Fröhlich M, Brenner H, Hombach V, Koenig W: Role of novel markers of inflammation in patients with stable coronary heart disease. Am J Cardiol 87: 262-266, 2001
17. Rifai N, Joubran R, Yu H, Asmi M, Jouma M: Inflammatory markers in men with angiographically documented coronary heart disease. Clin Chem 45: 1967-1973, 1999
18. Hojo Y, Ikeda U, Katsuki T, Mizuno O, Fukazawa H, Kurosaki H et al.: Interleukin-6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis. Heart 84: 83-87, 2000
19. Deliargyris EN, Raymond RJ, Theoharides TC, Boucher WS, Tate DA, Dehmer GJ: Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failure. Am J Cardiol 86: 913-918, 2000
20. Torzewski J, Torzewski M, Bowyer DE, Fröhlich M, Koenig W, Waltenberger J, Fitzsimmons C, Hombach V: C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 18: 1386-1392, 1998
21. Yasojima K, Schwab C, McGeer EG, McGeer PL: Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 158: 1039-1051, 2001
22. Meek RL, Urieli-Shoval S, Benditt EP: Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: Implications for serum amyloid A function. Proc Natl Acad Sci USA 91: 3186-3190, 1994
23. Artl A, Marsche G, Lestavel S, Sattler W, Malle E: Role of serum amyloid A during metabolism of acute-phase HDL by macrophages. Arterioscler Thromb Vasc Biol 20: 763-772, 2000
24. Esaki T, Hayashi T, Muto E, Yamada K, Kazuya M, Iguchi A: Expression of inducible nitric oxide synthase in T lymphocytes and macrophages of cholesterol-fed rabbits. Atherosclerosis 128: 439-446, 1997
25. Ishibashi T, Himeno M, Kubota K, Matsubara T, Hori T, Ozaki K, Yamazoe M, Aizawa Y, Yoshida J, Nishio M: Decrease in plasma NOx concentration by isosorbide dinitrate, an organic nitrate ester. J Cardiovasc Pharmacol (in press)
26. Maejima K, Himeno M, Ishibashi T, Nakano S, Nishio M, Uchida K: Paradoxical decrease in plasma NOx by L-arginine load in diabetic and non-diabetic subjects. Clin Exp Hypertension 24: 155-167, 2002
27. Keaney JF, Vita JA: Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action. Prog Cardiovasv Dis 38: 129-154, 1995
28. Beckman JS: Oxidative damage and tyrosine nitration from peroxynitrate. Chem Res Toxicol 9: 836-844, 1996